International Cancer Research Conference
March 24-26, 2025 | Singapore
Metastasis of Cancer
Metastasis is the spread of cancer cells to new parts of the body usually through the lymphatic system or the bloodstream. A metastatic cancer, also known as a metastatic tumor, has migrated beyond its original site of origin, or where it began to other parts of the body. Secondary tumors are tumors that develop from cells that have disseminated. The cancer may have migrated to nearby areas, which is known as Regional Metastasis, or to distant sections of the body, which is known as distant metastasis. Cancer's hallmark is metastasis, which is responsible for the majority of cancer-related deaths. Despite this, it is still poorly understood. Some of the molecular underpinnings of this dissemination process have been uncovered due to the ongoing evolution of cancer biology research and the emergence of new paradigms in the study of metastasis.
- Molecular Biology of Metastatic Cancer
- Dissemination and Invasion
- Circulation
- Intravasation and Extravasation
- Therapeutic Strategies
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Michael Thompson
University of Toronto, Canada
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Andrea González Báez
Autonomous University of Nuevo Leon, Mexico
Qian Zhang
The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, ChinaSubmit your abstract Today
Title :
Patricia Tai, Saskatchewan Cancer Agency, Canada
Title :
Atif A Ahmed, Seattle Children’s Hospital, United States
Title :
Marika Crohns, Sanofi, Germany
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada